Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1

Anesthesiology

Volumn 113, Issue 3, 2010, Pages 600-609

  Yuki, Koichi ^a,b,c   Astrof, Nathan S ^a,b,d   Bracken, Clay ^a,b,e   Sulpicio G Soriano, ^a,b,c   Shimaoka, Motomu ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; ISOFLURANE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; SEVOFLURANE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LEUKOCYTE; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; LEUKEMIA CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN BINDING;

ALLOSTERIC SITE; ANESTHETICS, INHALATION; HUMANS; JURKAT CELLS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; METHYL ETHERS; PROTEIN BINDING;

EID: 77956991873     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181e89a77     Document Type: Article

References (58)

1. Eckenhoff RG, Johansson JS: Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 1997; 49:343-367
2. Franks NP: General anaesthesia: From molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 2008; 9:370-386
3. Hemmings HC, Jr., Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL: Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005; 26:503-510
4. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. ANESTHESIOLOGY 2004; 100:707-721
5. Suleiman MS, Zacharowski K, Angelini GD: Inflammatory response and cardioprotection during open-heart surgery: The importance of anaesthetics. Br J Pharmacol 2008; 153:21-33
6. Mizobe T: Haematological effects of anaesthetics and anaesthesia. Curr Opin Anaesthesiol 1999; 12:437-441
7. McBride WT, Armstrong MA, McBride SJ: Immunomodulation: An important concept in modern anaesthesia. Anaesthesia 1996; 51:465-473
8. Kurosawa S, Kato M: Anesthetics, immune cells, and immune responses. J Anesth 2008; 22:263-277
9. Miles AA, Miles EM, Burke J: The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 1957; 38:79-96
10. Greif R, Akça O, Horn EP, Kurz A, Sessler DI: Supplemental perioperative oxygen to reduce the incidence of surgicalwound infection. Outcomes Research Group. N Engl J Med 2000; 342:161-167
11. Von Dossow V, Baur S, Sander M, Tønnesen H, Marks C, Paschen C, Berger G, Spies CD: Propofol increased the interleukin-6 to interleukin-10 ratio more than isoflurane after surgery in long-term alcoholic patients. J Int Med Res 2007; 35:395-405
12. Desai DM, Kuo PC: Perioperative management of special populations: Immunocompromised host (cancer, HIV, transplantation). Surg Clin North Am 2005; 85:1267- 82, xi-xii
13. Möbert J, Zahler S, Becker BF, Conzen PF: Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. ANESTHESIOLOGY 1999; 90:1372-1381
14. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, Peter K: Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. ANESTHESIOLOGY 1997; 86:188-195
15. Shayevitz JR, Rodriguez JL, Gilligan L, Johnson KJ, Tait AR: Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome. Shock 1995; 4:61-67
16. Reutershan J, Chang D, Hayes JK, Ley K: Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. ANESTHESIOLOGY 2006; 104:511-517
17. Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN: Anesthetics impact the resolution of inflammation. PLoS One 2008; 3:e1879
18. Shimaoka M, Takagi J, Springer TA: Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002; 31:485-516
19. Hynes RO: Integrins: Bidirectional, allosteric signaling machines. Cell 2002; 110:673-687
20. Dustin ML, Springer TA: Lymphocyte function associated-1 (LFA-1, CD11a/CD18), Guidebook to the Extracellular Matrix and Adhesion Proteins, 2nd Edition. Edited by Kreis T, Vale R. New York, Sambrook and Tooze, 1999, pp 228 -232
21. Evans R, Patzak I, Svensson L, De Filippo K, Jones K, McDowall A, Hogg N: Integrins in immunity. J Cell Sci 2009; 122:215-225
22. Shimaoka M, Springer TA: Therapeutic antagonists and the conformational regulation of integrin function. Nat Rev Drug Discov 2003; 2:703-716
23. Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J: Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci USA 2009; 106:4349-4354
24. Yuki K, Astrof NS, Bracken C, Yoo R, Silkworth W, Soriano SG, Shimaoka M: The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J 2008; 22: 4109-4116
25. Zhang H, Astrof NS, Liu JH, Wang JH, Shimaoka M: Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J 2009; 23: 2735-2740
26. Eckenhoff RG: Promiscuous ligands and attractive cavities: How do the inhaled anesthetics work? Mol Interv 2001; 1:258-268
27. Steurer M, Schläpfer M, Z'graggen BR, Booy C, Reyes L, Spahn DR, Beck-Schimmer B: The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol 2009; 155: 224-230
28. Lee HT, Chen SW, Doetschman TC, Deng C, D'Agati VD, Kim M: Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway. Am J Physiol Renal Physiol 2008; 295:F128 -36
29. Kidani Y, Taniguchi T, Kanakura H, Takemoto Y, Tsuda K, Yamamoto K: Sevoflurane pretreatment inhibits endotoxin- induced shock in rats. Anesth Analg 2005; 101:1152-1156
30. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA: An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci USA 2001; 98:2387-2392
31. McKenzie D, Franks NP, Lieb WR: Actions of general anaesthetics on a neuronal nicotinic acetylcholine receptor in isolated identified neurones of Lymnaea stagnalis. Br J Pharmacol 1995; 115:275-282
32. Watts MT, Escarzaga M, Williams CH: Gas chromatographic headspace analysis of sevoflurane in blood. J Chromatogr 1992; 577:289-298
33. Stevens R, Rüsch D, Solt K, Raines DE, Davies PA: Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols. J Pharmacol Exp Ther 2005; 314:338-345
34. Shimaoka M, Salas A, Yang W, Weitz-Schmidt G, Springer TA: Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in another. Immunity 2003; 19:391-402
35. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA: Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA 2001; 98:2393-2398
36. Shimaoka M, Xiao T, Liu JH, Yang Y, Dong Y, Jun CD, McCormack A, Zhang R, Joachimiak A, Takagi J, Wang JH, Springer TA: Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 2003; 112:99-111
37. Shimaoka M, Lu C, Palframan RT, von Andrian UH, McCormack A, Takagi J, Springer TA: Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin αL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci USA 2001; 98:6009-6014
38. Schleucher J, Schwendinger M, Sattler M, Schmidt P, Schedletzky O, Glaser SJ, Sørensen OW, Griesinger C: A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR 1994; 4:301-306
39. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD: 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 1995; 6:135-140
40. Kriwacki RW, Legge GB, Hommel U, Ramage P, Chung J, Tennant LL, Wright PE, Dyson HJ: Assignment of 1H, 13C and 15N resonances of the I-domain of human leukocyte function associated antigen-1. J Biomol NMR 2000; 16: 271-272
41. Zimmerman T, Oyarzabal J, Sebastián ES, Majumdar S, Tejo BA, Siahaan TJ, Blanco FJ: ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization. Chem Biol Drug Des 2007; 70:347-353
42. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A: NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995; 6:277-293
43. Weber C, Lu CF, Casasnovas JM, Springer TA: Role of αL β2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J Immunol 1997; 159:3968-3975
44. 4 integrin avidity but not of leukocyte function-associated antigen- I avidity to endothelial ligands under shear flow requires cholesterol membrane rafts. J Biol Chem 2002; 277:40027-40035
45. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T: Rap1 is a potent activation signal for leukocyte functionassociated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 2000; 20: 1956-1969
46. Carman CV, Springer TA: Integrin avidity regulation: Are changes in affinity and conformation underemphasized? Curr Opin Cell Biol 2003; 15:547-556
47. Zhang H, Liu JH, Yang W, Springer T, Shimaoka M, Wang JH: Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1. Proc Natl Acad Sci USA 2009; 106:18345-18350
48. Manderson GA, Johansson JS: Role of aromatic side chains in the binding of volatile general anesthetics to a fouralpha- helix bundle. Biochemistry 2002; 41:4080-4087
49. Yonkunas MJ, Xu Y, Tang P: Anesthetic interaction with ketosteroid isomerase: Insights from molecular dynamics simulations. Biophys J 2005; 89:2350-2356
50. Fang M, Tao YX, He F, Zhang M, Levine CF, Mao P, Tao F, Chou CL, Sadegh-Nasseri S, Johns RA: Synaptic PDZ domain- mediated protein interactions are disrupted by inhalational anesthetics. J Biol Chem 2003; 278:36669-36675
51. Last-Barney K, Davidson W, Cardozo M, Frye LL, Grygon CA, Hopkins JL, Jeanfavre DD, Pav S, Qian C, Stevenson JM, Tong L, Zindell R, Kelly TA: Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: Evidence for the allosteric inhibition of a protein-protein interaction. J Am Chem Soc 2001; 123:5643-5650
52. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U: Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7:687-692
53. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U: Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 1999; 292:1-9
54. Liu R, Loll PJ, Eckenhoff RG: Structural basis for highaffinity volatile anesthetic binding in a natural 4-helix bundle protein. FASEB J 2005; 19:567-576
55. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, Andreasen A, Viner A, Trudell JR, Harrison NL: Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 2001; 21:RC136
56. Stevens RJ, Rüsch D, Davies PA, Raines DE: Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors. Anesth Analg 2005; 100:1696-1703
57. Kash TL, Jenkins A, Harrison NL: Molecular volume determines the activity of the halogenated alkane bromoform at wild-type and mutant GABA(A) receptors. Brain Res 2003; 960:36-41
58. Etzioni A: Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 2010; 38:54-60